Notice: Undefined index: HTTP_ACCEPT_LANGUAGE in /home/juanedae/public_html/ambar-clinic/idiomas/idiomas.php on line 5
Ambar Clinic | Red Asistencial Juaneda

Innovation against Alzheimer's

Treatment objective
The AMBAR® treatment (Alzheimer Management by Albumin Replacement)* aims to slow the progression of Alzheimer's disease, slowing cognitive decline (memory loss, etc.) and improving patients' daily activities¹
Who can benefit?
People diagnosed with mild or moderate Alzheimer's disease.

The experience of a professional team with the most advanced technology

  • Dr. Fritz Nobbe

    Dr. Fritz Nobbe

    Neurologist
  • Dr. Fritz Nobbe, a neurologist, leads this programme at Clínica Juaneda, which is already one of the first four centres in Spain to offer this innovative clinical protocol developed by Grifols. He is supported by a highly specialised professional team, both in the management of this disease and in the development and application of the programme.

    What does it consist of?
    The AMBAR® treatment is carried out through a plasma exchange: a safe and well-known procedure, similar to a blood donation, with the difference that part of the patient's plasma, the liquid part of the blood, is extracted, and albumin, a natural protein of the body, is administered. The AMBAR® treatment can be used as a complement to other therapies.

    It seeks to remove harmful substances from the blood that can contribute to brain deterioration. During the session, the person lies comfortably while the device carries out the treatment through both arms. In general, it is well tolerated and, at the end, the person can return to daily activities normally.

    The treatment seeks to remove harmful substances from the blood that can contribute to brain deterioration.

    What experience exists?
    The AMBAR® treatment is the result of more than 20 years of international clinical research by GRIFOLS. It has been tested with positive and safe results in several clinical trials, including the AMBAR® clinical study, in which nearly 500 patients from Spain and the USA participated.

    1. Boada M et al. Alzheimers Dement. 2020;
    2. Costa M et al. Transfus Apher Sci. 2021;
    3. Boada M et al. Drugs News Perspect. 2009;
    4. Boada M et al. J Alzheimers Dis. 2019.

    For information about the AMBAR® treatment and to have a neurologist evaluate your case, please visit the hospital reception desk or contact us by email
    (ambar.clinic@juaneda.es) or call 971 280 000

    For more information

    Contact us, and we will advise you on everything you need
    Patient